Pilar Gallego
Instituto de Salud Carlos III(ES)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, Antiplatelet Therapy and Cardiovascular Diseases, Cardiac Arrhythmias and Treatments, Acute Ischemic Stroke Management
Most-Cited Works
- → Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy(2012)195 cited
- → The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation(2013)189 cited
- → Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey(2017)188 cited
- → Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation(2013)188 cited
- → Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation(2012)148 cited
- → SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation(2014)124 cited
- → Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)(2013)116 cited
- → High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation(2012)106 cited
- → Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021(2021)84 cited
- → Bridging Evidence-Based Practice and Practice-Based Evidence in Periprocedural Anticoagulation(2012)62 cited